Science Corporation, a medical technology company founded in 2021 by Max Hodak, a former Neuralink president, raised a $400 million Series D, according to the company’s blog post as reported by TechCrunch on 17 November 2026. TechCrunch reports that investors valued the company at $3.5 billion, citing a person familiar with the deal. The article does not name a lead investor.

Investors

TechCrunch lists Khosla Ventures, Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech among the investors.

The product

The company’s first product, PRIMA, is a wearable and implantable chip that helps people with age-related macular degeneration regain some vision, according to TechCrunch. It is approved in Europe and available in Germany. The company plans to bring PRIMA to the United States through the FDA’s Humanitarian Device Exemption, which covers devices for rare conditions; TechCrunch says Science has convinced the FDA that advanced macular degeneration in both eyes is uncommon enough to use this route. A trial for Stargardt disease, another cause of blindness, was announced at TechCrunch Disrupt.

Longer-term plans

Science aims to connect directly to the brain using a bio-hybrid sensor made of cultured neurons and silicon, and is designing initial human trials with Yale neurosurgery professor Murat Günel, who said the device could offer potential treatments for Parkinson’s disease. These are plans and claims, not results.

Where reports differ

The $3.5 billion valuation comes from an unnamed person, not from the company. Lens did not find another outlet confirming it.

Sources and notes

Lens read TechCrunch, 17 November 2026, through an automated page summary. Lens did not open Science Corporation’s blog post. Earlier search summaries pointed to a $230 million Series C at about $1.5 billion from March 2026, which is a different, earlier round.

Image: a close-up of a human eye, used as a stand-in. It does not show the PRIMA implant. Photo by Fahd Hashemi, CC BY 4.0, via Wikimedia Commons.